Aurinia Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
8.46
-0.06
(-0.7%)
Volume:
846,074
52 week range:
4.71 - 10.67
Market Cap:
1.162B
Company Description:
Aurinia Pharmaceuticals Inc. focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis.